Hoppe B - Search Results

1

Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.

Hoppe B, Dittlich K, Fehrenbach H, Plum G, Beck BB. Hoppe B, et al. Am J Kidney Dis. 2011 Sep;58(3):453-5. doi: 10.1053/j.ajkd.2011.05.012. Epub 2011 Jun 25. Am J Kidney Dis. 2011. PMID: 21705122

2

Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis.

Sikora P, Glatz S, Beck BB, Stapenhorst L, Zajaczkowska M, Hesse A, Hoppe B. Sikora P, et al. Among authors: hoppe b. Pediatr Nephrol. 2003 Oct;18(10):996-9. doi: 10.1007/s00467-003-1229-7. Epub 2003 Aug 13. Pediatr Nephrol. 2003. PMID: 12920632

3

Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria.

Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A. Hoppe B, et al. Front Biosci. 2003 Sep 1;8:e437-43. doi: 10.2741/1135. Front Biosci. 2003. PMID: 12957811 Review.

4

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B. Licht C, et al. Among authors: hoppe b. Am J Kidney Dis. 2005 Feb;45(2):415-21. doi: 10.1053/j.ajkd.2004.10.018. Am J Kidney Dis. 2005. PMID: 15685522

5

Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation.

Stapenhorst L, Sassen R, Beck B, Laube N, Hesse A, Hoppe B. Stapenhorst L, et al. Among authors: hoppe b. Pediatr Nephrol. 2005 May;20(5):652-6. doi: 10.1007/s00467-005-1831-y. Epub 2005 Mar 22. Pediatr Nephrol. 2005. PMID: 15782300

6

Primary hyperoxaluria--the German experience.

Hoppe B, Latta K, von Schnakenburg C, Kemper MJ. Hoppe B, et al. Am J Nephrol. 2005 May-Jun;25(3):276-81. doi: 10.1159/000086358. Epub 2005 Jun 15. Am J Nephrol. 2005. PMID: 15961947

7

Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.

Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A. Hoppe B, et al. Am J Kidney Dis. 2005 Sep;46(3):440-5. doi: 10.1053/j.ajkd.2005.06.003. Am J Kidney Dis. 2005. PMID: 16129205

8

Detection of polyomavirus BK and JC in children with kidney diseases and renal transplant recipients.

Müller A, Beck B, Theilemann K, Stapenhorst L, Licht C, Michalk D, Franzen C, Hoppe B. Müller A, et al. Among authors: hoppe b. Pediatr Infect Dis J. 2005 Sep;24(9):778-81. doi: 10.1097/01.inf.0000178071.05483.1c. Pediatr Infect Dis J. 2005. PMID: 16148843

9

Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?

Hoppe B, von Unruh G, Laube N, Hesse A, Sidhu H. Hoppe B, et al. Urol Res. 2005 Nov;33(5):372-5. doi: 10.1007/s00240-005-0497-z. Epub 2005 Nov 13. Urol Res. 2005. PMID: 16284877 Review.

10

A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.

Pieper AK, Haffner D, Hoppe B, Dittrich K, Offner G, Bonzel KE, John U, Fründ S, Klaus G, Stübinger A, Düker G, Querfeld U. Pieper AK, et al. Among authors: hoppe b. Am J Kidney Dis. 2006 Apr;47(4):625-35. doi: 10.1053/j.ajkd.2005.12.039. Am J Kidney Dis. 2006. PMID: 16564940 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters